ID   ISL1_RAT                Reviewed;         349 AA.
AC   P61374; P20663; P47894;
DT   24-MAY-2004, integrated into UniProtKB/Swiss-Prot.
DT   24-MAY-2004, sequence version 1.
DT   02-OCT-2024, entry version 159.
DE   RecName: Full=Insulin gene enhancer protein ISL-1;
DE            Short=Islet-1;
GN   Name=Isl1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RC   TISSUE=Keratinocyte;
RX   PubMed=7907017; DOI=10.1210/endo.134.3.7907017;
RA   Wang M., Drucker D.J.;
RT   "The LIM domain homeobox gene isl-1: conservation of human, hamster, and
RT   rat complementary deoxyribonucleic acid sequences and expression in cell
RT   types of nonneuroendocrine lineage.";
RL   Endocrinology 134:1416-1422(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   STRAIN=Wistar;
RA   Liu J., Chen D., Zheng Y., Meng X., Liu Y.;
RT   "Variation of insulin gene enhancer binding protein Isl-1.";
RL   Submitted (FEB-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-316 (ISOFORM 1), DNA-BINDING, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=1691825; DOI=10.1038/344879a0;
RA   Karlsson O., Thor S., Norberg T., Ohlsson H., Edlund T.;
RT   "Insulin gene enhancer binding protein Isl-1 is a member of a novel class
RT   of proteins containing both a homeo- and a Cys-His domain.";
RL   Nature 344:879-882(1990).
CC   -!- FUNCTION: DNA-binding transcriptional activator. Recognizes and binds
CC       to the consensus octamer binding site 5'-ATAATTAA-3' in promoter of
CC       target genes. Plays a fundamental role in the gene regulatory network
CC       essential for retinal ganglion cell (RGC) differentiation. Cooperates
CC       with the transcription factor POU4F2 to achieve maximal levels of
CC       expression of RGC target genes and RGC fate specification in the
CC       developing retina. Involved in the specification of motor neurons in
CC       cooperation with LHX3 and LDB1 (By similarity). Binds to insulin gene
CC       enhancer sequences (PubMed:1691825). Essential for heart development.
CC       Marker of one progenitor cell population that give rise to the outflow
CC       tract, right ventricle, a subset of left ventricular cells, and a large
CC       number of atrial cells as well, its function is required for these
CC       progenitors to contribute to the heart. Controls the expression of FGF
CC       and BMP growth factors in this cell population and is required for
CC       proliferation and survival of cells within pharyngeal foregut endoderm
CC       and adjacent splanchnic mesoderm as well as for migration of cardiac
CC       progenitors into the heart (By similarity).
CC       {ECO:0000250|UniProtKB:P61372}.
CC   -!- SUBUNIT: At neuronal promoters, displaces LDB1 from LHX3 LIM domain to
CC       form a ternary complex in which ISL1 contacts both LHX3 and LDB1;
CC       allosteric structural changes in the DNA binding domain of LHX3,
CC       induced by the ISL1:LHX3 interaction, may explain differences in
CC       sequence specificity of the different complexes. Interacts with LHX3.
CC       Interacts (via C-terminus) with POU4F2 (via C-terminus) isoform 1.
CC       Interacts with POU3F2. Interacts with POU4F3. Interacts (via N-terminal
CC       domain) with MLIP; the interaction represses ISL1 transactivator
CC       activity. Interacts with GCN5/KAT2A. Interactions of ISL1 with MLIP1 or
CC       KAT2A may be mutually exclusive (By similarity).
CC       {ECO:0000250|UniProtKB:P61372}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250|UniProtKB:P61372}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Isl1-alpha;
CC         IsoId=P61374-1; Sequence=Displayed;
CC       Name=2; Synonyms=Isl1-beta;
CC         IsoId=P61374-2; Sequence=VSP_010339;
CC   -!- TISSUE SPECIFICITY: Expressed in islet cells of the pancreas
CC       (PubMed:1691825, PubMed:7907017). {ECO:0000269|PubMed:1691825,
CC       ECO:0000269|PubMed:7907017}.
CC   -!- PTM: Ubiquitinated probably by WWP1 E3 ubiquitin ligase; ubiquitination
CC       is followed by protein degradation. {ECO:0000250|UniProtKB:P61372}.
CC   -!- PTM: Phosphorylated. {ECO:0000250|UniProtKB:P61372}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S69329; AAB30128.1; -; mRNA.
DR   EMBL; AY557632; AAS46773.1; -; mRNA.
DR   EMBL; X53258; CAA37349.1; -; mRNA.
DR   PIR; I67417; I67417.
DR   RefSeq; NP_059035.3; NM_017339.3. [P61374-1]
DR   AlphaFoldDB; P61374; -.
DR   SMR; P61374; -.
DR   STRING; 10116.ENSRNOP00000017305; -.
DR   PhosphoSitePlus; P61374; -.
DR   PaxDb; 10116-ENSRNOP00000017305; -.
DR   GeneID; 64444; -.
DR   KEGG; rno:64444; -.
DR   AGR; RGD:61957; -.
DR   CTD; 3670; -.
DR   RGD; 61957; Isl1.
DR   VEuPathDB; HostDB:ENSRNOG00000012556; -.
DR   eggNOG; KOG0490; Eukaryota.
DR   HOGENOM; CLU_027802_2_0_1; -.
DR   InParanoid; P61374; -.
DR   OrthoDB; 2880952at2759; -.
DR   PhylomeDB; P61374; -.
DR   TreeFam; TF315442; -.
DR   PRO; PR:P61374; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000012556; Expressed in stomach and 9 other cell types or tissues.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:RGD.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:UniProtKB.
DR   GO; GO:0043425; F:bHLH transcription factor binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISO:RGD.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001046; F:core promoter sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISO:RGD.
DR   GO; GO:0030274; F:LIM domain binding; IMP:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0030331; F:nuclear estrogen receptor binding; IDA:BHF-UCL.
DR   GO; GO:0016922; F:nuclear receptor binding; IDA:BHF-UCL.
DR   GO; GO:1990841; F:promoter-specific chromatin binding; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IDA:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISO:RGD.
DR   GO; GO:0060413; P:atrial septum morphogenesis; ISO:RGD.
DR   GO; GO:0031103; P:axon regeneration; IEP:RGD.
DR   GO; GO:0007409; P:axonogenesis; IBA:GO_Central.
DR   GO; GO:0060070; P:canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0060913; P:cardiac cell fate determination; ISO:RGD.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; ISO:RGD.
DR   GO; GO:0003215; P:cardiac right ventricle morphogenesis; ISO:RGD.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEP:BHF-UCL.
DR   GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; IEP:RGD.
DR   GO; GO:0003203; P:endocardial cushion morphogenesis; ISO:RGD.
DR   GO; GO:0007507; P:heart development; ISS:UniProtKB.
DR   GO; GO:0003007; P:heart morphogenesis; ISO:RGD.
DR   GO; GO:0060384; P:innervation; ISO:RGD.
DR   GO; GO:0048762; P:mesenchymal cell differentiation; ISO:RGD.
DR   GO; GO:0090090; P:negative regulation of canonical Wnt signaling pathway; ISO:RGD.
DR   GO; GO:0050680; P:negative regulation of epithelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISO:RGD.
DR   GO; GO:0033147; P:negative regulation of intracellular estrogen receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0072201; P:negative regulation of mesenchymal cell proliferation; IMP:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; IDA:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0001755; P:neural crest cell migration; ISO:RGD.
DR   GO; GO:0030182; P:neuron differentiation; ISO:RGD.
DR   GO; GO:0048663; P:neuron fate commitment; ISO:RGD.
DR   GO; GO:0048665; P:neuron fate specification; ISO:RGD.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0003148; P:outflow tract septum morphogenesis; ISO:RGD.
DR   GO; GO:0031016; P:pancreas development; ISO:RGD.
DR   GO; GO:0048936; P:peripheral nervous system neuron axonogenesis; ISO:RGD.
DR   GO; GO:0048935; P:peripheral nervous system neuron development; ISO:RGD.
DR   GO; GO:0060037; P:pharyngeal system development; ISO:RGD.
DR   GO; GO:0021983; P:pituitary gland development; ISO:RGD.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0090280; P:positive regulation of calcium ion import; IMP:RGD.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; ISS:UniProtKB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0010718; P:positive regulation of epithelial to mesenchymal transition; IMP:BHF-UCL.
DR   GO; GO:0071657; P:positive regulation of granulocyte colony-stimulating factor production; ISO:RGD.
DR   GO; GO:0032725; P:positive regulation of granulocyte macrophage colony-stimulating factor production; ISO:RGD.
DR   GO; GO:0032024; P:positive regulation of insulin secretion; IMP:RGD.
DR   GO; GO:0032730; P:positive regulation of interleukin-1 alpha production; ISO:RGD.
DR   GO; GO:0032731; P:positive regulation of interleukin-1 beta production; ISO:RGD.
DR   GO; GO:0032735; P:positive regulation of interleukin-12 production; ISO:RGD.
DR   GO; GO:0032755; P:positive regulation of interleukin-6 production; ISO:RGD.
DR   GO; GO:1901258; P:positive regulation of macrophage colony-stimulating factor production; ISO:RGD.
DR   GO; GO:0033138; P:positive regulation of peptidyl-serine phosphorylation; IMP:RGD.
DR   GO; GO:0045880; P:positive regulation of smoothened signaling pathway; IDA:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0032760; P:positive regulation of tumor necrosis factor production; ISO:RGD.
DR   GO; GO:2000676; P:positive regulation of type B pancreatic cell apoptotic process; IMP:RGD.
DR   GO; GO:0032729; P:positive regulation of type II interferon production; ISO:RGD.
DR   GO; GO:0042531; P:positive regulation of tyrosine phosphorylation of STAT protein; ISO:RGD.
DR   GO; GO:0010575; P:positive regulation of vascular endothelial growth factor production; ISO:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0010468; P:regulation of gene expression; ISO:RGD.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; ISO:RGD.
DR   GO; GO:0003266; P:regulation of secondary heart field cardioblast proliferation; ISO:RGD.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISO:RGD.
DR   GO; GO:0003139; P:secondary heart field specification; ISO:RGD.
DR   GO; GO:0048880; P:sensory system development; ISO:RGD.
DR   GO; GO:0060931; P:sinoatrial node cell development; ISO:RGD.
DR   GO; GO:0021520; P:spinal cord motor neuron cell fate specification; ISO:RGD.
DR   GO; GO:0021522; P:spinal cord motor neuron differentiation; ISO:RGD.
DR   GO; GO:0048863; P:stem cell differentiation; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0021559; P:trigeminal nerve development; ISO:RGD.
DR   GO; GO:0055010; P:ventricular cardiac muscle tissue morphogenesis; ISO:RGD.
DR   GO; GO:0021524; P:visceral motor neuron differentiation; ISO:RGD.
DR   CDD; cd00086; homeodomain; 1.
DR   CDD; cd09366; LIM1_Isl; 1.
DR   CDD; cd09374; LIM2_Isl; 1.
DR   Gene3D; 2.10.110.10; Cysteine Rich Protein; 2.
DR   Gene3D; 1.10.10.60; Homeodomain-like; 1.
DR   InterPro; IPR001356; HD.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR009057; Homeodomain-like_sf.
DR   InterPro; IPR047169; ISL1/2-like.
DR   InterPro; IPR047244; ISL1/2-like_LIM1.
DR   InterPro; IPR001781; Znf_LIM.
DR   PANTHER; PTHR24204; INSULIN GENE ENHANCER PROTEIN; 1.
DR   PANTHER; PTHR24204:SF4; INSULIN GENE ENHANCER PROTEIN ISL-1; 1.
DR   Pfam; PF00046; Homeodomain; 1.
DR   Pfam; PF00412; LIM; 2.
DR   SMART; SM00389; HOX; 1.
DR   SMART; SM00132; LIM; 2.
DR   SUPFAM; SSF57716; Glucocorticoid receptor-like (DNA-binding domain); 2.
DR   SUPFAM; SSF46689; Homeodomain-like; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 2.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Developmental protein; Differentiation;
KW   DNA-binding; Homeobox; LIM domain; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc.
FT   CHAIN           1..349
FT                   /note="Insulin gene enhancer protein ISL-1"
FT                   /id="PRO_0000075749"
FT   DOMAIN          17..70
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          79..133
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DNA_BIND        181..240
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   REGION          262..291
FT                   /note="LIM-binding domain (LID)"
FT                   /evidence="ECO:0000250"
FT   REGION          312..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        312..341
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   VAR_SEQ         256..278
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_010339"
FT   CONFLICT        67
FT                   /note="C -> S (in Ref. 2; AAS46773)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        199
FT                   /note="C -> R (in Ref. 2; AAS46773)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   349 AA;  39036 MW;  4DB82FD09154F404 CRC64;
     MGDMGDPPKK KRLISLCVGC GNQIHDQYIL RVSPDLEWHA ACLKCAECNQ YLDESCTCFV
     RDGKTYCKRD YIRLYGIKCA KCSIGFSKND FVMRARSKVY HIECFRCVAC SRQLIPGDEF
     ALREDGLFCR ADHDVVERAS LGAGDPLSPL HPARPLQMAA EPISARQPAL RPHVHKQPEK
     TTRVRTVLNE KQLHTLRTCY AANPRPDALM KEQLVEMTGL SPRVIRVWFQ NKRCKDKKRS
     IMMKQLQQQQ PNDKTNIQGM TGTPMVAASP ERHDGGLQAN PVEVQSYQPP WKVLSDFALQ
     SDIDQPAFQQ LVNFSEGGPG SNSTGSEVAS MSSQLPDTPN SMVASPIEA
//
